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Driven by million-fold improvements in biotechnology, biology is increasingly shifting towards high-resolution,
quantitative approaches to study the molecular dynamics of entire populations. One exciting application enabled
by this new era of biology is the “digital immune system”. It would work in much the same way as an adaptive,
biological immune system: by observing the microbial landscape, detecting potential threats, and neutralizing them
before they spread beyond control. With the potential to have an enormous impact on public health, it is time to
integrate the necessary biotechnology, computational, and organizational systems to seed the development of a
global, sequencing-based pathogen surveillance system.The “mega-genomics” era
If the last two decades marked the beginning of the gen-
omics era, starting with the sequencing and publication
of the first free-living organism in 1995 and then the
human genome in 2001, the current decade marks the
beginning of the “mega-genomics” era, where large num-
bers of genomes are analyzed with diverse, sequencing-
based assays to infer molecular diversity and dynamics of
life. Examples include projects to determine the molecu-
lar basis of complex human diseases such as cancer [1],
to study the incredible diversity and function of the
human microbiome [2], to rapidly identify the origins of
pathogen outbreaks [3], and to generally develop a deeper
understanding of the living world through the increasing
use of large-scale sequencing.
These breakthroughs are driven by a shift from single-
reference genomics to more quantitative, population-
wide analyses. Biology has moved beyond developing a
merely qualitative understanding of cellular and evolu-
tionary processes, and now strives for base-pair reso-
lution and predictive models of biological systems and
disease. This has been enabled through the combination
of dramatically improved biotechnology, computer
technology, algorithms, and statistical models. Through
sophisticated protocols and assays, sequencing is no
longer limited to just reading DNA, but has been cre-
atively adapted to measure transcript abundance, pro-
tein-DNA binding patterns, and the three-dimensional* Correspondence: mschatz@cshl.edu
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distribution, and reproduction in any mediumconfiguration of DNA or RNA, among others (see [4] for a
overview of available applications). Sequencing throughput
and costs have improved by more than a million-fold, and
these advances have risen alongside similarly radical
advances in computational technology and algorithm
sophistication [5].
Amazingly, there seems to be no end to the exponen-
tial capability growth we have witnessed, and vendor
roadmaps continue to project breakneck innovation well
into the next decade. Worldwide sequencing capacities
currently exceed 15 petabases per year, and compute
clouds with seemingly infinite capacity can now be
rented on demand. On the sequencing side, real-time,
single-molecule sequencing has been achieved by Pacific
Biosciences, and Oxford Nanopore has promised to
deliver a mobile, disposable sequencing device the size of
a thumb-drive [6]. With equally amazing advancements
happening every year, it is virtually certain that the con-
fluence of cheap sequencing and “big data” computer
science will enable many new, digital forms of biology.A digital immune system
One exciting application of digital biology with the poten-
tial to have enormous public health impact is the “digital
immune system.” The term, coined by David Lipman of
NCBI, draws an analogy between computing and biology—
a recurring technique of computational scientists (viruses,
genetic algorithms, neural networks). A digital immune
system would work in much the same way as an adaptive,
biological immune system: by observing the microbial
landscape, detecting potential threats, and neutralizing
them before they cause widespread harm. This simpleCentral Ltd. This is an Open Access article distributed under the terms of the
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start to be replicated in silico with the combination of dis-
tributed “sensor” sequencing and bioinformatics—where a
network of mobile sequencing devices serves a real-time
stream of microbial genomes to a global compute cloud
for analysis.
An effective immune response relies on the ability to
differentiate normal from abnormal. In the digital realm,
this ability will rely on extensive knowledge of microbial
diversity. However, unlike the macroscopic world where
outliers can often be easily recognized, microbial diversity
is less well characterized, with only a small fraction of the
world’s microbes ever sequenced [7]. It is difficult to
characterize an emerging outbreak, for example, when
only a handful of known genomes exist. Effective patho-
gen detection and response requires a complete catalog
of genomic diversity, antibiotic resistance, and virulence
across both temporal and geospatial dimensions. This
must be achieved by sequencing and archiving huge
numbers of microbial genomes, both from clinical cases
and known environmental reservoirs, on a continual
basis.
Just as an immunological memory improves with each
exposure, genome databases will also expand and
improve over time as new outbreaks and environments
are analyzed, but only if this digital memory is properly
managed. Standardized sequences and metadata must
be made freely available in real-time and on a global
scale, requiring a daunting level of cooperation. The
primary nucleotide archives NCBI, EMBL and DDBJ are
obvious candidates for this task, but these archives must
rapidly adapt to the new era of population sequencing.
The current database models are outdated; the number
of genomes being submitted lags far behind the
genomes being sequenced and those submitted often
lack essential metadata. Barriers must be eliminated and
new incentives structured to encourage the submission
of usable, large-scale data: “more data, faster” should be
the guiding principle and the minimum metadata of
“what, where, when” (sequence, location, time) must be
reliably captured.
An explosion of openly available microbial genomes,
linked with temporal and geospatial metadata, would
undoubtedly lead to new discoveries in epidemiology and
ultimately lead to more predictive biology. Open data
sharing has already reduced outbreak attribution to a
matter of weeks, as evidenced by the “crowd-sourced”
responses to the swine flu [8] and Escherichia coli O104:
H4 [9] outbreaks, while the NIAID Influenza Genome
Sequencing Project, spearheaded by The Institute for
Genomic Research (now JCVI) [10], has hinted at the
predictive potential. Influenza research has exploded with
the ongoing generation and release of these genomes,
spawning many follow-on studies and predictive modelsthat have shown, among other things, that seasonal influ-
enza severity can be predicted by the genetic diversity of
the circulating strains [11]. The potential power of
expanding such surveillance efforts is extremely compel-
ling and would drastically shape the future of infectious
disease—potentially stopping the next outbreak before it
happens.
The technology necessary to implement these proposals
is imminent, although a few significant obstacles remain.
Computational hurdles, while daunting, are perhaps the
most manageable, with computer science, high-energy
physics, and astronomy already leading the big-data
charge. Rather, a more pressing need is for inexpensive
and portable sequencing devices that can act as the sensors
in a distributed, real-time sequencing network—just as
atmospheric sensors feed real-time data to sophisticated
weather modeling programs. These sequencing sensors
would also require significant advances in sample prepar-
ation to allow easy nucleic acid extraction direct from any
sample, so that they could be widely deployed and oper-
ated by health care providers rather than specialists.
As the necessary technologies continue to grow to ad-
dress these needs, there is no need to wait. Recent studies
have shown that implementing this vision on a limited
scale can yield tremendous insight (e.g. [12]). In addition,
many universities and hospitals already perform routine
pathogen sequencing and environmental screens. What is
needed now is an organized effort towards making these
genomes as widely available as possible to enable a digital
immune system with the potential to drastically advance
human health.
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